News

CADTH is pleased to announce the introduction of the Real-World Evidence (RWE) Guidance Working Group which reports to the Real-World Evidence Steering Committee. The objective of this Guidance Working Group is to develop clear and comprehensive guidance on the conduct, reporting, and appraising of…

Held in April or May every year since 2005, the CADTH Symposium has traditionally been a spring event. Because of the COVID-19 pandemic, the 2020 CADTH Symposium was delayed until late fall and we continued with a fall date in 2021. Now we are preparing for a return to the CADTH Symposium’s…

CADTH is pleased to announce the successful collaborators of its inaugural Post-Market Drug Evaluation (PMDE) Network. Collaborators will bring additional expertise to the PMDE Network and will respond to decision-makers’ queries by providing expertise and evidence in the post-market space. The…

CADTH is pleased to announce the release of a new report entitled Building Toward a Potential Pan-Canadian Formulary: A Report From the Advisory Panel. In July 2021, the Government of Canada approached CADTH to develop a recommended framework for creating and managing a potential pan-Canadian…

CADTH is undertaking an innovative review for an antiviral treatment to address the recent monkeypox outbreaks. Monkeypox has become a serious public health issue around the globe. According to WHO, the most recent case fatality ratio from monkeypox infection is about 3% to 6%. The causes of death…